Application no. and date | 11850585.8 (espacenet) (Federated) (European Patent Register), 20110630 | Patent/reg. no. and date | DK/EP 2657234, 20170111 | Publication date | 20131030 | Priority no. and date | WO PCT/JP2010/073093, 20101222 | EP pub. no. and date |
EP 2657234 20131030 | Effective date | | Applicant/owner | Meiji Seika Pharma Co., Ltd, 4-16, Kyobashi 2-chome Chuo-ku Tokyo 104-8002, JP | Applicant ref. no. | 60831DK01 | Inventor | ABE, Takao, c/o Meiji Seika Pharma Co.,Ltd. 760, Moroka-cho, Kouhoku-ku Yokohama-shi
Kanagawa 222-8567, JP, OKUE, Masayuki, c/o Meiji Seika Pharma Co.,Ltd. 760, Moroka-cho, Kouhoku-ku Yokohama-shi
Kanagawa 222-8567, JP, SAKAMAKI, Yoshiaki, c/o Meiji Seika Pharma Co.,Ltd. 760, Moroka-cho, Kouhoku-ku Yokohama-shi
Kanagawa 222-8567, JP | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | Opponent | | IPC Class | A61K 31/439 (2006.01) , A61P 31/04 (2006.01) , A61P 43/00 (2006.01) , C07D 211/60 (2006.01) , C07D 471/08 (2006.01) | Title | Optisk aktivt diazabicyclooctanderivat og fremgangsmåde til fremstilling heraf | Int. application no. | JP2011065001 | Int. publication no. | WO2012086241 | Related patent (certificate) | | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|